Thomas Huber

Preclinical Antitumor Activity of a Novel Anti–c-KIT Antibody–Drug Conjugate against Mutant and Wild-type c-KIT–Positive Solid Tumors

Tinya J. Abrams, Anu Connor, Christie Fanton et al. · Clinical Cancer Research · 2018 · 66 citations

Medicine, Oncology, Pharmacology +15

First‐in‐human study demonstrating the safety and clinical efficacy of novel anti‐IL‐17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis

Martin Kaul, Philip Jarvis, Izabela Rozenberg et al. · Journal of the European Academy of Dermatology and Venereology · 2020 · 28 citations · Full text

Medicine, Dermatology, Immunology +17

PCA062, a P-cadherin Targeting Antibody–Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin–expressing Malignancies

Qing Sheng, Joseph A. D’Alessio, Daniel L. Menezes et al. · Molecular Cancer Therapeutics · 2021 · 22 citations

Medicine, Oncology, Pharmacology +13

An ANGPTL4 inhibitory antibody safely improves lipid profiles in non-human primates

Beryl B. Cummings, Page Bouchard, Mark Milton et al. · EBioMedicine · 2025 · 12 citations · Full text

Medicine, Cardiology, Pharmacology +17